Howard E. Boudreau, Ph.D.

Molecular Defenses Section

NIH Main Campus, Bethesda, MD

Howard E. Boudreau, Ph.D.

Staff Scientist

Provides direct clinical care to patients at NIH Clinical Center

Howard E. Boudreau, Ph.D.

Major Areas of Research

  • NADPH oxidase (NOX) enzyme function 
  • Inflammation
  • Wound healing
  • Cancer metastasis
     

Program Description

We are currently investigating the role of mutant p53-induced NOX4 on the cancer cell secretome, and the effects NOX4-derived reactive oxygen species have on the inflammatory tumor microenvironment.

Biography

Education

Ph.D., 2006, Georgetown University

Howard Boudreau obtained his Ph.D. in Biochemistry and Molecular & Cellular Biology from Georgetown University in 2006. His graduate work focused on identifying and characterizing novel effector targets of the Raf-1/ERK signaling pathway in metastatic breast cancer. As a post-doctoral fellow at NIH/NIAID, he focused on roles of NADPH oxidase (NOX) enzymes in TGF-beta-mediated inflammation and wound healing. In 2014, he joined the Molecular Defenses Section (MDS) as a Staff Scientist in the Laboratory of Clinical Immunology and Microbiology (LCIM) and studies how tumor-associated mutant p53 proteins and NOX4 contribute to cancer cell migration and inflammation.

Selected Publications

Ma WF, Boudreau HE, Leto TL. Pan-Cancer Analysis Shows TP53 Mutations Modulate the Association of NOX4 with Genetic Programs of Cancer Progression and Clinical Outcome. Antioxidants (Basel). 2021 Feb 4;10(2):235.

Boudreau HE, Leto TL. Model Systems to Investigate NOX-Dependent Cell Migration and Invasiveness. Methods Mol Biol. 2019;1982:473-485.

Sugamata R, Donko A, Murakami Y, Boudreau HE, Qi CF, Kwon J, Leto TL. Duox1 Regulates Primary B Cell Function under the Influence of IL-4 through BCR-Mediated Generation of Hydrogen Peroxide. J Immunol. 2019 Jan 15;202(2):428-440. 

Boudreau HE, Ma WF, Korzeniowska A, Park JJ, Bhagwat MA, Leto TL. Histone modifications affect differential regulation of TGFβ- induced NADPH oxidase 4 (NOX4) by wild-type and mutant p53. Oncotarget. 2017 Jul 4;8(27):44379-44397. 

Boudreau HE, Casterline BW, Burke DJ, Leto TL. Wild-type and mutant p53 differentially regulate NADPH oxidase 4 in TGF-β-mediated migration of human lung and breast epithelial cells. Br J Cancer. 2014 May 13;110(10):2569-82.

Visit PubMed for a complete publication list

Content last reviewed on